Infectious complications of solid organ transplantations (Q34305102)

1 August 2017

1 reference

title

Infectious complications of solid organ transplantations (English)

1 reference

1 August 2017

Simon DM

1

1 reference

1 August 2017

Levin S

series ordinal

2

1 reference

1 August 2017

publication date

1 June 2001

1 reference

Infectious Disease Clinics of North America

1 August 2017

published in

1 reference

1 August 2017

volume

15

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

521-549

1 reference

Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

1 reference

7 January 2021

Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Infections in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Pneumonia After Heart Transplantation: A Multiinstitutional Study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Risk factors for invasive fungal infections complicating orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Infection in organ-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Infectious complications of lung transplantation. Impact of cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Outcome of kidney transplant recipients with previous human herpesvirus-8 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Toxoplasmosis in heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Bacterial Infection as a Complication of Liver Transplantation: Epidemiology and Risk Factors

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Urological complications after kidney-pancreas transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Transplanted infections: donor-to-host transmission with the allograft

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Betaherpesviruses in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Infection in the transplanted and native lung after single lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Primary-Effusion Lymphoma and Kaposi's Sarcoma in a Cardiac-Transplant Recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

1 reference

7 January 2021

Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

1 reference

7 January 2021

Primary and reactivated toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Infectious complications following pancreatic transplantation: incidence, microbiological and clinical characteristics, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Infectious complications following isolated lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Comparative risk of bloodstream infection in organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Toxoplasmosis in pediatric recipients of heart transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Opportunistic strongyloidiasis in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Rhodococcus equi infection in transplant recipients: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Lung transplantation: the Cleveland Clinic experience

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Infections in solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Infective endocarditis in solid organ transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Invasive aspergillosis in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Fungal infections in solid-organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Transmission of tuberculosis by kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Infections in heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Posttransplant infection in enteric versus bladder-drained simultaneous pancreas-kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Current status of intestinal transplantation in children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Infectious disease complications of renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Blastomycosis in transplant recipients: report of a case and review

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Bacteremia after intestinal transplantation in children correlates temporally with rejection or gastrointestinal lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

INVASIVE ASPERGILLOSIS IN LIVER TRANSPLANT RECIPIENTS IN THE 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low-dose amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Mycobacterium tuberculosisInfection in Solid‐Organ Transplant Recipients: Impact and Implications for Management

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Selective decontamination in pediatric liver transplants. A randomized prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Epidemiology of legionella pneumonia and factors associated with legionella-related mortality at a tertiary care center.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Bacterial and fungal infections after liver transplantation: an analysis of 284 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Actinomycosis, nocardiosis, and actinomycetoma

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Aspergillus infection in single and double lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

Infections in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970158-6

7 January 2021

10.1016/S0891-5520(05)70158-6

Identifiers

DOI

1 reference

1 August 2017

1 reference